Navigation Links
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
Date:5/13/2013

00 p.m. Pacific Time with management to discuss results from the meeting as well as financial results for the first quarter and provide a general corporate update.

About Anthera PharmaceuticalsAnthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases.  Anthera's Phase 3 development product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy, or IgAN, lupus nephritis, vasculitis, rheumatoid arthritis, idiopathic thrombocytopenia purpura, and others.

Safe Harbor Statement

Any statements contained in this press release that refer to future events or other non-historical matters, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," "project," or similar statements, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in Anthera's public filings with the SEC, including Anthera's Annual Report on Form 10-K for the year ended December 31, 2012 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2013.  Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Dennis Lutz of Anthera Pharmaceuticals, Inc., dlutz@anthera.com
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
2. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
3. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
4. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
5. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
6. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
7. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
8. Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit
9. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
10. Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting
11. Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... and consumables for the medical, research, and veterinary markets ... and research markets in the United States ... purchase agreement to acquire 100% of QCR & Trio ... based distribution organization. The transaction closed on November 17, ...
(Date:11/21/2014)...  Edwards Lifesciences Corporation (NYSE: EW ), ... and hemodynamic monitoring, announced today that it will increase ... strong launch of Edwards Lifesciences Foundation,s new charitable initiative, ... global communities where its employees live and work. ... exceed $8 million, including more than $7 million in ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014  The ... at the 2014 AAGL Global Congress demonstrates continued ... insert designed to provide bowel control. One of the ... Associate Professor and Division Chief of Urogynecology and ... Carolina, won an Award for Best Written Abstract ...
Breaking Medicine Technology:Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3
... Eurotech , a leading supplier of embedded technologies, ... to supply embedded computers to a medical ...  The value of the six-month contract is about 1.5M ... Sphere II will allow the customer to meet market ...
... GENEVA and LOS ANGELES, Aug. 30, 2011 ... and consulting firm serving the life sciences industry, ... Switzerland consistent with its global growth strategy. The ... linguistic regions. They will be closely aligned with ...
Cached Medicine Technology:Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application 2Bench International Expands Presence in Europe with Opening of Offices in Switzerland 2
(Date:11/23/2014)... 2014 For the coming special Friday, ... launched a great promotion for many products, especially the ... get the best choice with amazing discounts, up to ... , It is easy to buy colored wedding ... this selection is also famous for delicate craftsmanship, elegant ...
(Date:11/23/2014)... friends have more influence on teens, alcohol use than ... "We,ve known for a long time that ... use, but there are no common studies that distinguished ... influence on those decisions," Jonathon Beckmeyer, an assistant professor ... a university news release. Beckmeyer analyzed data gathered ...
(Date:11/23/2014)... high quality access control power suppliers are popular in ... new collection of power suppliers. Additionally, it has launched ... All the new models come with big discounts, up ... 20, 2014. , SWAccessControl.com has thousands of happy customers, ... a long time. It is very wise to visit ...
(Date:11/23/2014)... Church, VA (PRWEB) November 23, 2014 ... TV Have in Common, **FDAnews On-Demand Webinar**, Dec. 11, ... http://www.fdanews.com/TheFDAisWatchingOnDemand , The FDA’s focus on promotional activities ... , Now they're looking at websites, Twitter, ... Mark the calendar for Thursday, Dec. 11, for On-Demand ...
(Date:11/22/2014)... Every year AlignLife clinics nationwide team together ... growth in the Greenville, SC area in 2014 and ... of Simpsonville will be partnering with the 5 ... Toy Drive. These six offices came together to decide ... year's toy drive. With so many amazing organizations to ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2
... from a University of Pittsburgh study demonstrate that intensity-modulated ... be uniformly delivered in a large health care system ... planning and treatment process. The findings were presented today ... for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles. ...
... Therap Services will attend,the 2nd International Conference on ... - 8, 2007 in Bangkok, Thailand. The,conference, co- ... the,theme "Resources and Roadmaps." Therap Services will be ... Therap Services will participate in a poster session ...
... low-risk version of a condition called gastroschisis varies greatly by ... with the condition have a hole in their abdomen near ... the hole is the only abdominal anomaly, is fairly easy ... the Hopkins findings suggest that in some hospitals, far fewer ...
... 26, 2007 MedImmune, Inc. today announced it will ... (AAP) 2007 National Conference & Exhibition, adding to the ... respiratory syncytial virus (RSV), a leading cause of hospitalization ... data that provide key insights into how we can ...
... , , FRIDAY, Oct. 26 (HealthDay News) -- Halloween costume? Check. ... tips? Safety tips? , Yes, safety tips . , ... he or she is armed with a checklist of "dos" ... night for all. , Topping the list -- be ...
... Medical Center, a,privately held, 420-bed medical center serving the ... a voluntary Chapter 11 petition in the,United States Bankruptcy ... In connection with the filing, Brotman Medical Center ... revolver in the amount of,approximately $19.6 million to be ...
Cached Medicine News:Health News:Integrated approach to IMRT provides quality care for head and neck cancer patients 2Health News:Therap Services to Attend 2nd International Conference on Intellectual Disabilities/Mental Retardation as Gold Sponsor 2Health News:MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics 2Health News:A Happy Halloween Means Safety First 2Health News:A Happy Halloween Means Safety First 3Health News:A Happy Halloween Means Safety First 4Health News:Brotman Medical Center Facilitates Restructuring Through Chapter 11 Filing 2
... Immunosimplicity (Is) Rubella IgG Test Kit ... qualitative and quantitative detection of antibodies ... performed either manually or in conjunction ... The results are reported in IU/ml,which ...
... is the first,diagnostic hepatitis assay approved by ... run in a random access format on,the ... you,can run a hepatitis test at any ... intended for,the qualitative in vitro determination of ...
... ANOGEN's ELISA-PSA kit is ... the quantitative,measurement of prostatic specific ... This in vitro device is,strictly ... screening, management and prognosis of ...
... a comprehensive line of pregnancy tests including ... in convenient one-step stick and cassette formats. ... Clearview Easy HCG is a 25 mIU ... Clearview HCG II provides 25mIU sensitivity ...
Medicine Products: